Sagimet Biosciences Inc. - Series A · NASDAQ:SGMT
Point72 Asset Management, L.P. reported a 5.70% stake in Sagimet Biosciences Inc. - Series A (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 15, 2025
Point72 Asset Management, L.P. reported a 5.70% stake in Sagimet Biosciences Inc. - Series A, 1,755,143 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).
- Stake
- 5.70%
- Shares
- 1,755,143
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Point72 Asset Management, L.P. | 5.70% | 1,755,143 |
| Point72 Capital Advisors, Inc. | 5.70% | 1,755,143 |
| Steven A. Cohen | 5.70% | 1,755,143 |
Source
Related
- Sagimet Biosciences Inc. - Series A
- Point72 Asset Management, L.P.
- Sagimet Biosciences Inc. - Series A shareholders
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2025
- Schedule 13G · Commodore Capital LP · Oct 7, 2026
- Form 4 · Kemble George · Aug 17, 2026
- Schedule 13G · Balyasny Asset Management L.P. · Aug 14, 2026
- Form 4 · Kemble George · Aug 12, 2026
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026